Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 285 institutions reported holding it in 13F filings for Q3 2026, worth $3.15B in total; no superinvestor holds it.
Holders of 5% or more of DNLI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Denali Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13G/A | 12.30%19.6M shares | +2.10 ppfrom 10.20% | May 15, 20263 filings | Nov 16, 2026 | SEC |
| Baillie Gifford & Co | 13G/A | 7.50%12.0M shares | −1.10 ppfrom 8.60% | Jan 12, 20216 filings | Aug 4, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.20%10.5M shares | – | Oct 21, 20243 filings | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
46 Schedule 13D and 13G filings on Denali Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 202610:02 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 12.30%19.6M shares | +2.10 ppfrom 10.20% | Sep 30, 2026 | SEC |
| Aug 4, 20269:11 AM ET | Baillie Gifford & Co | 13G/A | 7.50%12.0M shares | −1.10 ppfrom 8.60% | Jun 30, 2026 | SEC |
| Jul 8, 202611:30 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 10.20%16.2M shares | +4.80 ppfrom 5.40% | Jun 30, 2026 | SEC |
| May 15, 202610:06 AM ET | T. Rowe Price Investment Management, Inc. | 13G | 5.40%8.52M shares | New | Mar 31, 2026 | SEC |
| May 6, 202611:13 AM ET | FMR LLCand 1 other | 13G/A | 4.20%6.67M shares | −1.60 ppfrom 5.80%Below 5% | Mar 31, 2026 | SEC |
| Mar 26, 20266:06 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 5, 202511:30 AM ET | FMR LLCand 1 other | 13G/A | 5.80%8.54M shares | – | Sep 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 3.90%5.66M shares | –Below 5% | Jun 30, 2025 | SEC |
| Apr 17, 20253:05 PM ET | BlackRock, Inc. | 13G/A | 7.20%10.5M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 20252:14 PM ET | Capital Research Global Investors | 13G/A | 3.80%5.48M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 202510:52 AM ET | Baillie Gifford & Co | 13G/A | 8.60%12.3M shares | – | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Capital Research Global Investors | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Nov 7, 20244:48 PM ET | Biogen Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Aug 16, 2024 | FMR LLC | 13GOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Bratton Douglas K | 13G/AOld format | – | – | – | SEC |
| Feb 12, 20247:07 PM ET | Biogen Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2024 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Jan 30, 2024 | Temasek Holdings (Private) Ltd | 13G/AOld format | – | – | – | SEC |
| Jan 30, 2024 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20244:59 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Mar 30, 2023 | Temasek Holdings (Private) Ltd | 13GOld format | – | New | – | SEC |
| Feb 13, 2023 | Bratton Douglas K | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20235:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 2023 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Bratton Douglas K | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | ARCH Venture Fund VIII, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 18, 2022 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Flagship Ventures Fund V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Bratton Douglas K | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20212:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 2, 2021 | ARCH Venture Fund VIII, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 12, 2021 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
78 notices from officers, directors and other affiliates planning to sell Denali Therapeutics Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 20268:38 PM ET | Chin Peter ScottOfficer | 1.65K | $36.9K | Sep 4, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 2, 20264:31 PM ET | Nancy ThornberryDirector | 11.4K | $266.1K | Sep 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 1, 20264:47 PM ET | Alexander SchuthOfficer | 2.77K | $65.8K | Sep 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 11, 20265:39 PM ET | Schuth Alexander O.Officer | 2.86K | $71.6K | Aug 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 5, 20264:14 PM ET | Carole HoFormer affiliate | 39.5K | $801.4K | Feb 5, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 4, 20264:16 PM ET | Carole HoFormer affiliate | 150.0K | $3.18M | Feb 4, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 3, 20264:47 PM ET | Carole HoFormer affiliate | 150.0K | $3.32M | Feb 3, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 6, 20268:28 PM ET | Ho CaroleConsultant | 17.2K | $284.1K | Jan 6, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 6, 20268:25 PM ET | Schuth Alexander O.Officer | 17.2K | $284.1K | Jan 6, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 6, 20268:24 PM ET | Watts Ryan J.Director · Officer | 35.2K | $580.8K | Jan 6, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 4, 20254:41 PM ET | Carole HoOfficer | 1.88K | $35.8K | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 13, 20254:45 PM ET | Carole HoOfficer | 806 | $10.7K | Aug 13, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 12, 20258:46 PM ET | Schuth Alexander O.Officer | 2.94K | $39.9K | Aug 12, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 12, 20258:44 PM ET | Ho CaroleOfficer | 2.94K | $39.9K | Aug 12, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 9, 20254:13 PM ET | Watts Ryan J.Officer | 495.3K | $7.10M | Jul 9, 202510b5-1 | Jefferies LLC | SEC |
| Jan 7, 20258:14 PM ET | Ho CaroleOfficer | 2.91K | $60.5K | Jan 7, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:12 PM ET | Schuth Alexander O.Officer | 2.91K | $60.5K | Jan 7, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:10 PM ET | Watts Ryan J.Director · Officer | 7.65K | $159.2K | Jan 7, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:08 PM ET | Krognes Steve E.Director | 3.34K | $69.5K | Jan 7, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:06 PM ET | Schuth Alexander O.Officer | 12.3K | $247.8K | Jan 6, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:03 PM ET | Watts Ryan J.Director · Officer | 29.3K | $591.7K | Jan 6, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 7, 20258:01 PM ET | Ho CaroleOfficer | 12.3K | $247.8K | Jan 6, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 2, 20254:23 PM ET | Vicki Lee SatoDirector | 6.16K | $125.5K | Jan 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 31, 20244:17 PM ET | Steve KrognesDirector | 30.0K | $607.2K | Dec 31, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 20247:47 AM ET | David SchenkeinDirector | 59.4K | $1.86M | Nov 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the DNLI notices from the last 12 months